Videos

Jessica Ailani, MD: Delving Deeper into the Status of Patients With Migraine

The director of the MedStar Georgetown University Hospital Headache Center stressed building a culture of teaching patients to be their own advocates and to build the relationship with the patient to better manage their migraines.

Jessica Ailani, MD: Continuing to Improve Acute Migraine Care

The director of the MedStar Georgetown University Hospital Headache Center discussed the development of acute care options for patients to improve their quality of life and the management of their condition.

Emergent Treatment of Migraine: Should I Go to the ED?

Richard B. Lipton, MD, and Stephen Silberstein, MD, comment on the recommended protocol for patients seen in the emergency department and discuss when inpatient care is necessary for the treatment of chronic migraine.

Brian Grosberg, MD: Device Development in Migraine

The director of the Hartford Headache Center spoke about the trend toward device use in migraine treatment, and some of the reasons that may have prompted it.

An FDA Warning Letter, the Amyloid Hypothesis and Alzheimer Disease, Adverse Events with Triptan Use

Neurology News Network for the week of November 12, 2018.

Brian Grosberg, MD: Nerivio Migra Device for Acute Migraine Treatment

The director of the Hartford Healthcare Headache Center in Connecticut and lead investigator on the trial provided some insight into the study's findings.

Ricardo Osorio, MD: Unanswered Questions About the Relationship Between Sleep, Alzheimer Disease

The associate professor at NYU Langone discussed several of the questions that remained unanswered about the relationship between sleep and Alzheimer disease.

Asher J. Albertson, MD, PhD: Getting Interventions to Stroke Patients

Albertson discussed this facet of stroke care, and all the things being done outside just the clinic to help improve outcomes.

Ricardo Osorio, MD, on the Association Between Sleep-Wake Disruptions, Pathogenesis of Alzheimer

The associate professor at NYU Langone discussed emerging evidence that suggests that sleep disruption results in higher levels of markers associated with Alzheimer disease.

Next Page >>